- Q4 2023 Fate Therapeutics Inc Earnings Call TranscriptFeb 26, 2024$6.95 (-0.14%)Earnings
- Q3 2023 Fate Therapeutics Inc Earnings Call TranscriptNov 08, 2023$2.33 (+0.87%)Earnings
- Q2 2023 Fate Therapeutics Inc Earnings Call TranscriptAug 08, 2023$3.53 (-0.56%)Earnings
- Fate Therapeutics Inc at Goldman Sachs Healthcare Conference TranscriptJun 13, 2023
- Fate Therapeutics Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Q1 2023 Fate Therapeutics Inc Earnings Call TranscriptMay 03, 2023$6.32 (+6.76%)Earnings
- Fate Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 14, 2023
- Q4 2022 Fate Therapeutics Inc Earnings Call TranscriptFeb 28, 2023$6.12 (+1.83%)Earnings
- Fate Therapeutics Inc at Cowen IO Next Summit (Virtual) TranscriptNov 11, 2022
- Q3 2022 Fate Therapeutics Inc Earnings Call TranscriptNov 03, 2022$19.45 (-2.94%)Earnings
- Fate Therapeutics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Q2 2022 Fate Therapeutics Inc Earnings Call TranscriptAug 03, 2022$32.81 (+7.12%)Earnings
- Fate Therapeutics Inc at Bank of America Healthcare Conference TranscriptMay 12, 2022
- Q1 2022 Fate Therapeutics Inc Earnings Call TranscriptMay 04, 2022$30.69 (+6.64%)Earnings
- Fate Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 16, 2022
- Q4 2021 Fate Therapeutics Inc Earnings Call TranscriptFeb 28, 2022$34.55 (-1.09%)Earnings
- Fate Therapeutics Inc at Guggenheim Partners Healthcare Talks Oncology Days (Virtual) TranscriptFeb 09, 2022
- Fate Therapeutics Inc Phase 1 FT516 and FT596 Clinical Data Update Call TranscriptDec 14, 2021
- Fate Therapeutics Inc Investor Event - Corporate Call TranscriptNov 15, 2021
- Q3 2021 Fate Therapeutics Inc Earnings Call TranscriptNov 04, 2021$59.65 (-1.21%)Earnings
- Fate Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 10, 2021
- Fate Therapeutics Inc Interim Phase 1 Clinical Data for NHL Programs Call TranscriptAug 19, 2021
- Q2 2021 Fate Therapeutics Inc Earnings Call TranscriptAug 04, 2021$85.73 (+2.98%)Earnings
- Fate Therapeutics Inc at Bank of America NAPA Healthcare Conference TranscriptJun 15, 2021
- Fate Therapeutics Inc Annual Shareholders Meeting TranscriptJun 02, 2021
- Fate Therapeutics Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 01, 2021
- Fate Therapeutics Inc Interim Phase 1 Clinical Data for AML Programs Corporate Call TranscriptMay 13, 2021
- Q1 2021 Fate Therapeutics Inc Earnings Call TranscriptMay 05, 2021$77.73 (-2.51%)Earnings
- Fate Therapeutics Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 11, 2021
- Fate Therapeutics Inc at SVB Leerink Global Healthcare Conference (Virtual) TranscriptFeb 25, 2021
- Q4 2020 Fate Therapeutics Inc Earnings Call TranscriptFeb 24, 2021$95.27 (-0.22%)Earnings
- Q3 2020 Fate Therapeutics Inc Earnings Call TranscriptNov 05, 2020$49.92 (+0.20%)Earnings
- Q2 2020 Fate Therapeutics Inc Earnings Call TranscriptAug 05, 2020$32.84 (+0.67%)Earnings
- Q1 2020 Fate Therapeutics Inc Earnings Call TranscriptMay 11, 2020$30.22 (+4.79%)Earnings
- Q4 2019 Fate Therapeutics Inc Earnings Call TranscriptMar 02, 2020$31.01 (+6.20%)Earnings
- Q3 2019 Fate Therapeutics Inc Earnings Call TranscriptNov 05, 2019$15.71 (+2.68%)Earnings
- Fate Therapeutics, Inc. Presents at Citi's 14th Annual Biotech Conference, Sep-04-2019 01:30 PM TranscriptSep 04, 2019
- Q2 2019 Fate Therapeutics Inc Earnings Call TranscriptAug 06, 2019$19.82 (+2.85%)Earnings
- Q1 2019 Fate Therapeutics Inc Earnings Call TranscriptMay 07, 2019$16.98 (-5.19%)Earnings
- Q4 2018 Fate Therapeutics Inc Earnings Call TranscriptMar 05, 2019$16.03 (-1.05%)Earnings
Fate Therapeutics Inc at Jefferies Healthcare Conference Transcript
Welcome, everyone. Thank you for joining us on another great afternoon session here at the Jefferies Healthcare Conference. Up here on the stage with us for another great fireside chat is the President and CEO of Fate Therapeutics, Scott Wolchko.
Scott, it has been an interesting journey over the last couple of years, but importantly, a lot of learnings on NK biology, cell therapy, and so many things going on, I would love to just maybe offer you the opportunity to briefly give us a snapshot of Fate as it stands here today in the middle of 2023, had a reset with the pipeline.
Questions & Answers
You actually had an announcement earlier this morning about a new NK program that just saw the IND. So that's going to be in stream. But like Wall Street has been pretty confused about the potential for NK cell therapy. And you've been pioneering the way, then had some disappointments. So where do we stand today with Fate and with your pipeline? And why should we be excited today on Fate?
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)